Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Melanoma 30Neoplasm Metastasis 17Skin Neoplasms 9Leukemia, Myeloid, Acute 8Neoplasms 7Kidney Neoplasms 7Ovarian Neoplasms 6Carcinoma, Renal Cell 6Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Neuroblastoma 4Lymphoma, Non-Hodgkin 4Leukemia 4Breast Neoplasms 4Lymphoma 3Lung Neoplasms 3Congenital Abnormalities 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Triple Negative Breast Neoplasms 2Sezary Syndrome 2Rectal Neoplasms 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Cyclophosphamide 2thymoglobulin 1plerixafor 1fludarabine phosphate 1fludarabine 1aldesleukin 1Thiotepa 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytarabine 1Clofarabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Myeloid × aldesleukin × Clear all
NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡